Consensus on the secondary prevention of primary liver cancer
Yuemin Nan(Hebei Medical University), Jidong Jia(National Clinical Research Center for Digestive Diseases), Junqi Niu(Jilin University), Yanyan Yu(Nanchang University), Lai Wei(Nanjing University of Finance and Economics), Weifeng Zhao(Guangzhou University of Chinese Medicine), Xiaoyuan Xu(Columbia University), Lingdi Liu(Hebei Medical University), Huiguo Ding(Capital Medical University), Chuanmiao Xie(Sun Yat-sen University), Suxian Zhao, Yuguo Zhang(Wuhan University), Zhongping Duan(Capital Medical University), Yanhang Gao(Jilin University), Wengang Li(Xiamen University), Qinmao Fang, Hui Zhuang(Institute of Crop Sciences), Jian Zhou, Jingfeng Liu(Fujian Medical University), Jian-Gao Fan, Ming Yang(Fudan University), Peng Hu(Peking University), Wen Xie(University of Pittsburgh), Jia Shang(European Foundation for the Study of Chronic Liver Failure), Rongqi Wang(Sichuan University)
Cited by 17
Related Papers
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
Dual-Channel Photoelectrochemical Ratiometric Aptasensor with up-Converting Nanocrystals Using Spatial-Resolved Technique on Homemade 3D Printed Device
|Analytical Chemistry|2018|329
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
|Journal of Experimental & Clinical Cancer Research|2015|271